Leadership

Management

Ronald J. Zenk

President and CEO

Mr. Zenk is the the President, CEO, member of the Board of Directors and Founder of Humanetics Corporation.

John C. Dykstra

Chief Operating Officer

Mr. Dykstra has served as Chief Operating Officer of Humanetics since 1998 and is a member of the Board of Directors.

Colin Chinn

Chief Medical Officer

Dr. Chinn serves as Chief Medical Officer for Humanetics.

Michael D. Kaytor, Ph.D.

Vice President of Research and Development

Dr. Kaytor joined Humanetics in 2012 and serves as the Vice President of Research and Development.

Scott R. Thatcher

Director of Chemistry, Manufacturing and Controls

Mr. Thatcher joined Humanetics in 2023 as Director of CMC.

Board of Directors

Admiral Matthew L. Nathan, M.D.

Director

Admiral Nathan has served as a member of the Board since 2020 and as Chairman since 2022.

Timothy E. Morris

Director

Mr. Morris joined the Board in 2021.

Barbara R. Holcomb, RN, BSN, MSN

Director

General Holcomb joined the Board in 2023.

Ronald J. Zenk

President and CEO

Mr. Zenk has served as a member of the Board since 1988.

John C. Dykstra

Chief Operating Officer

Mr. Dykstra has served as a member of the Board since 1999.

Jake R. Nunn

Director

Mr. Nunn joined the Board in 2022.

Thomas F. Jasper

Director

Mr. Jasper has served as a member of the Board since 2022.

Medical and Programmatic Advisors

Karen L. Smith, MD, Ph.D.

Biotech/Pharmaceutical Executive, Board Director and Clinical/Scientific Advisor in the US, Europe, Canada and Australia

Dr. Smith is an accomplished executive with expertise in clinical design

Robert C. Miller, MD

Professor of Radiation Oncology, University of Maryland School of Medicine

Dr. Miller is a practicing radiation oncologist within the University of Maryland School of Medicine and is the Medical Director of the Maryland Proton Treatment Center.

Douglas W. Bryce

Advisor - CBRN Medical Countermeasure Contracting.

Mr. Bryce served as the Joint Program Executive Officer, Chemical, Biological, Radiological and Nuclear Defense.

Scientific Advisors

Isabel L. Jackson, Ph.D.

Assistant Professor of Radiation Oncology, University of Maryland

Dr. Jackson's area of expertise is focused on understanding the mechanisms underlying radiation effects in tissue.

Michael R. Landauer, Ph.D.

Scientist Emeritus, Armed Forces Radiobiology Research Institute

Dr. Landauer is a radiation countermeasure consultant.

Ronald G. Manning, Ph.D.

Former Chief, Chemical, Radiological and Nuclear Medical Countermeasures, BARDA

Dr. Manning is a distinguished scientists that has expertise in development of Medical Countermeasures.